Lee Seong Ho, Ko Kyungtae, Choo Min Soo, Lee Won Ki, Jeong Hyun Cheol, Cho Sung Tae, Kim Sung Yong, Kim Hayoung, Kang Won Hwa, Kim Gun Poong, Yang Dae Yul
Department of Urology, College of Medicine, Hallym University, Chuncheon, Korea.
J Biomed Mater Res B Appl Biomater. 2015 Feb;103(2):440-7. doi: 10.1002/jbm.b.33221. Epub 2014 Jun 7.
The aim of this study is to evaluate whether polylactic acid (PLA) microspheres and adipose-derived stromal vascular fraction (SVF) cells have appropriate properties as an injectable bulking agent in urologic field. Forty male Sprague-Dawley rats (2-week-old) were randomized into two groups. A total of 0.05 mL of PLA microsphere suspension and 0.05 mL of PLA microsphere suspension mixed with PKH26-labeled SVF cells were injected into bladder wall in group I and group II, respectively. At 2, 8, 16, and 24 weeks of PLA microspheres injection, the volumes of implants were measured and bladder tissues including implants were analyzed and compared grossly and histologically between groups. The distant organs were examined histologically to determine migration of PLA microspheres. At 24 weeks of implantation, 65-70% of injected volume was maintained and there was no significant difference between groups. In histological analyses, injected PLA microspheres were localized in muscular layer of bladder without infiltration into adjacent layer. From 8 to 16 weeks of injection, hybrid tissues contained collagen and actin were observed between PLA microspheres and these findings were more clear in group II. PHK26-labeled SVF cells were identified by fluorescence microscopy at all time points. There was no migration of PLA microspheres to other organs and no abnormality in weight gain and hematologic values. These results suggest the possibility of PLA microspheres as a potentially useful bulking agent in urologic field. And further investigation is needed to know synergic effect of SVF cells.
本研究的目的是评估聚乳酸(PLA)微球和脂肪源性基质血管成分(SVF)细胞作为泌尿外科领域可注射填充剂是否具有合适的特性。将40只雄性Sprague-Dawley大鼠(2周龄)随机分为两组。分别将0.05 mL的PLA微球悬液和0.05 mL与PKH26标记的SVF细胞混合的PLA微球悬液注入I组和II组的膀胱壁。在注射PLA微球后的第2、8、16和24周,测量植入物的体积,并对包括植入物在内的膀胱组织进行大体和组织学分析及组间比较。对远处器官进行组织学检查以确定PLA微球的迁移情况。植入24周时,维持了65%-70%的注射体积,组间无显著差异。组织学分析显示,注入的PLA微球位于膀胱肌层,未浸润至相邻层。注射8至16周时,在PLA微球之间观察到含有胶原蛋白和肌动蛋白的混合组织,且在II组中这些发现更明显。在所有时间点通过荧光显微镜均鉴定出PKH26标记的SVF细胞。PLA微球未迁移至其他器官,体重增加和血液学值也无异常。这些结果表明PLA微球作为泌尿外科领域潜在有用的填充剂具有可能性。并且需要进一步研究以了解SVF细胞的协同作用。